Gottlieb Promotes 'Team' Work For Product Reviews
US FDA Commissioner intends to change agency's siloed structure and move reviewers into teams that will follow products pre- and post-market.
US FDA Commissioner intends to change agency's siloed structure and move reviewers into teams that will follow products pre- and post-market.